FDA.reportPublic FDA data

Senna S

Product NDC
41163-160
11-digit product format
411630160
Labeler code
41163
Product ID
41163-160_b1c488cf-a9f7-443d-9d4f-8da67f07f835
Type
HUMAN OTC DRUG
Nonproprietary name
DOCUSATE SODIUM, SENNOSIDES
Dosage form
TABLET
Route
ORAL
Labeler
EQUALINE (SuperValu)
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2013-03-15
Marketing end
2019-12-31
Substance
DOCUSATE SODIUM; SENNOSIDES
Active strength
50 mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct41163-160DDiscontinued by firm2026-10-05
excluded packagepackage41163-16041163-160-30DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage41163-160-30d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage41163-160-30f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage41163-160-302ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage41163-160-30a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage41163-160-30cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage41163-160-30cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage41163-160-30302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage41163-160-30ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage41163-160-300efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage41163-160-30ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage41163-160-30367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage41163-160-30557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DOCUSATE SODIUMACTIVE INGREDIENTF05Q2T2JA0SENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
SENNOSIDESACTIVE INGREDIENT3FYP5M0IJXSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
DOCUSATEACTIVE MOIETYM7P27195AGSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
SENNOSIDESACTIVE MOIETY3FYP5M0IJXSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933SENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEINACTIVE INGREDIENTO7TSZ97GEPSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61USENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48SENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOASENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8SENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30SENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ASENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
POLYVINYL ALCOHOLINACTIVE INGREDIENT532B59J990SENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4SENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
TALCINACTIVE INGREDIENT7SEV7J4R1USENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2
WATERINACTIVE INGREDIENT059QF0KO0RSENNA S (DOCUSATE SODIUM, SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]2